检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Phase I/II Study of the Activin Receptor-Like Kinase 2 (ALK2) Inhibitor Zilurgisertib (INCB000928, LIMBER-104) as Monotherapy or With Ruxolitinib in Patients With Anemia Due to Myelofibrosis

Prithviraj Bose,Sanjay Mohan,Stephen Oh,Jason Gotlib,Ellen Ritchie,Taizo Shimomura,Haris Ali,Francoise Boyer,Paola Guglielmelli,Anthony Hunter,Betty Lamothe,Yi Cui,Francis Seguy,Amanda McBride,Francesca Palandri,Masahiro Takeuchi,Jean-Jacques Kiladjian

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

引用 0|浏览15
暂无评分
关键词
MPN,myelofibrosis,Janus kinase,anemia,hepcidin,Phase I
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要